Sign Up to like & get
recommendations!
1
Published in 2017 at "Gastroenterology"
DOI: 10.1016/s0016-5085(17)33572-2
Abstract: Background The once-daily fixed-dose combination tablet of sofosbuvir/velpatasvir/voxilaprevir(SOF/VEL/VOX) was evaluated for the treatment of genotype 1–6 HCV infection in four Phase 3 studies in direct-acting antiviral (DAA)-experienced (POLARIS-1 and POLARIS-4) and DAA-naive (POLARIS-2 and POLARIS-3)…
read more here.
Keywords:
polaris polaris;
sof vel;
weeks daa;
polaris ... See more keywords